Literature DB >> 21128703

Mitochondria and redox signaling in steatohepatitis.

E Matthew Morris1, R Scott Rector, John P Thyfault, Jamal A Ibdah.   

Abstract

Alcoholic and nonalcoholic fatty liver diseases are potentially pathological conditions that can progress to steatohepatitis, fibrosis, and cirrhosis. These conditions affect millions of people throughout the world in part through poor lifestyle choices of excess alcohol consumption, overnutrition, and lack of regular physical activity. Abnormal mitochondrial and cellular redox homeostasis has been documented in steatohepatitis and results in alterations of multiple redox-sensitive signaling cascades. Ultimately, these changes in signaling lead to altered enzyme function and transcriptional activities of proteins critical to mitochondrial and cellular function. In this article, we review the current hypotheses linking mitochondrial redox state to the overall pathophysiology of alcoholic and nonalcoholic steatohepatitis and briefly discuss the current therapeutic options under investigation.

Entities:  

Mesh:

Year:  2011        PMID: 21128703      PMCID: PMC3118705          DOI: 10.1089/ars.2010.3795

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  234 in total

1.  The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis.

Authors:  Glen Lutchman; Apurva Modi; David E Kleiner; Kittichai Promrat; Theo Heller; Marc Ghany; Brian Borg; Rohit Loomba; T Jake Liang; Ahalya Premkumar; Jay H Hoofnagle
Journal:  Hepatology       Date:  2007-08       Impact factor: 17.425

Review 2.  Effect of weight loss on nonalcoholic fatty liver disease.

Authors:  Anish A Patel; Dawn M Torres; Stephen A Harrison
Journal:  J Clin Gastroenterol       Date:  2009 Nov-Dec       Impact factor: 3.062

3.  Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.

Authors:  Makoto Nakamuta; Motoyuki Kohjima; Shusuke Morizono; Kazuhiro Kotoh; Tsuyoshi Yoshimoto; Izuru Miyagi; Munechika Enjoji
Journal:  Int J Mol Med       Date:  2005-10       Impact factor: 4.101

4.  Ethanol increases mitochondrial cytochrome P450 2E1 in mouse liver and rat hepatocytes.

Authors:  Marie-Anne Robin; Ingrid Sauvage; Thomas Grandperret; Véronique Descatoire; Dominique Pessayre; Bernard Fromenty
Journal:  FEBS Lett       Date:  2005-12-01       Impact factor: 4.124

5.  Lactate sensitive transcription factor network in L6 cells: activation of MCT1 and mitochondrial biogenesis.

Authors:  Takeshi Hashimoto; Rajaa Hussien; Saji Oommen; Kishorchandra Gohil; George A Brooks
Journal:  FASEB J       Date:  2007-03-29       Impact factor: 5.191

Review 6.  Redox regulation of hepatocyte apoptosis.

Authors:  Carmen Garcia-Ruiz; José C Fernández-Checa
Journal:  J Gastroenterol Hepatol       Date:  2007-06       Impact factor: 4.029

Review 7.  Role of mitochondria in non-alcoholic fatty liver disease.

Authors:  Dominique Pessayre
Journal:  J Gastroenterol Hepatol       Date:  2007-06       Impact factor: 4.029

8.  Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.

Authors:  Steven E Nissen; Kathy Wolski
Journal:  N Engl J Med       Date:  2007-05-21       Impact factor: 91.245

9.  The effect of a silybin-vitamin e-phospholipid complex on nonalcoholic fatty liver disease: a pilot study.

Authors:  Carmela Loguercio; Alessandro Federico; Marco Trappoliere; Concetta Tuccillo; Ilario de Sio; Agnese Di Leva; Marco Niosi; Mauro Valeriano D'Auria; Rita Capasso; Camillo Del Vecchio Blanco
Journal:  Dig Dis Sci       Date:  2007-04-05       Impact factor: 3.199

Review 10.  Regulation of Nox and Duox enzymatic activity and expression.

Authors:  J David Lambeth; Tsukasa Kawahara; Becky Diebold
Journal:  Free Radic Biol Med       Date:  2007-04-01       Impact factor: 7.376

View more
  21 in total

1.  Thymic NF-κB-inducing kinase regulates CD4+ T cell-elicited liver injury and fibrosis in mice.

Authors:  Hong Shen; Liang Sheng; Yi Xiong; Yeung-Hyen Kim; Lin Jiang; Zheng Chen; Yong Liu; Kalyani Pyaram; Cheong-Hee Chang; Liangyou Rui
Journal:  J Hepatol       Date:  2017-03-06       Impact factor: 25.083

Review 2.  Role of mitochondria in alcoholic liver disease.

Authors:  Fatiha Nassir; Jamal A Ibdah
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

3.  Heat shock protein 72 regulates hepatic lipid accumulation.

Authors:  Ashley E Archer; Robert S Rogers; Alex T Von Schulze; Joshua L Wheatley; E Matthew Morris; Colin S McCoin; John P Thyfault; Paige C Geiger
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-06-20       Impact factor: 3.619

4.  PGC-1α overexpression results in increased hepatic fatty acid oxidation with reduced triacylglycerol accumulation and secretion.

Authors:  E Matthew Morris; Grace M E Meers; Frank W Booth; Kevin L Fritsche; Christopher D Hardin; John P Thyfault; Jamal A Ibdah
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-08-16       Impact factor: 4.052

5.  Liver-specific loss of Perilipin 2 alleviates diet-induced hepatic steatosis, inflammation, and fibrosis.

Authors:  Charles P Najt; Subramanian Senthivinayagam; Mohammad B Aljazi; Kelly A Fader; Sandra D Olenic; Julienne R L Brock; Todd A Lydic; A Daniel Jones; Barbara P Atshaves
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-03-11       Impact factor: 4.052

Review 6.  Emerging role of redox dysregulation in alcoholic and nonalcoholic fatty liver disease.

Authors:  Ariel E Feldstein; Shannon M Bailey
Journal:  Antioxid Redox Signal       Date:  2011-05-25       Impact factor: 8.401

7.  Impaired ketogenesis and increased acetyl-CoA oxidation promote hyperglycemia in human fatty liver.

Authors:  Justin A Fletcher; Stanisław Deja; Santhosh Satapati; Xiaorong Fu; Shawn C Burgess; Jeffrey D Browning
Journal:  JCI Insight       Date:  2019-04-23

8.  CYP2E1-dependent and leptin-mediated hepatic CD57 expression on CD8+ T cells aid progression of environment-linked nonalcoholic steatohepatitis.

Authors:  Ratanesh Kumar Seth; Suvarthi Das; Ashutosh Kumar; Anindya Chanda; Maria B Kadiiska; Gregory Michelotti; Jose Manautou; Anna Mae Diehl; Saurabh Chatterjee
Journal:  Toxicol Appl Pharmacol       Date:  2013-11-07       Impact factor: 4.219

9.  Reduced hepatic mitochondrial respiration following acute high-fat diet is prevented by PGC-1α overexpression.

Authors:  E Matthew Morris; Matthew R Jackman; Grace M E Meers; Ginger C Johnson; Jordan L Lopez; Paul S MacLean; John P Thyfault
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-10-03       Impact factor: 4.052

Review 10.  Gastrointestinal and hepatic manifestations of mitochondrial disorders.

Authors:  Shamima Rahman
Journal:  J Inherit Metab Dis       Date:  2013-05-15       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.